Skip to content

Efficacy of repetitive transcranial magnetic stimulation in the treatment of idiopathic facial nerve palsy

Efficacy of repetitive transcranial magnetic stimulation in the treatment of idiopathic facial nerve palsy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600129198
Enrollment
Unknown
Registered
2026-07-31
Start date
2026-08-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Idiopathic facial nerve palsy (Bell's palsy)

Interventions

Experimental group:Active magnetic stimulation combined with electrical stimulation
Control group:Sham magnetic stimulation combined with electrical stimulation

Sponsors

Tongji Hospital of Tongji University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Age >=18 years, both genders; 2. Meet diagnostic criteria for idiopathic facial nerve palsy; 3. First episode, unilateral facial paralysis; 4. Time from onset to enrollment <=6 months; 5. Baseline House-Brackmann grade II-V; 6. Willing to sign written informed consent.

Exclusion criteria

Exclusion criteria: 1. Non-idiopathic facial nerve palsy (e.g., Ramsay Hunt syndrome, traumatic, neoplastic, postoperative, congenital, or iatrogenic); 2. Previous or current definite central nervous system diseases; 3. Active ear diseases or infections, or skin lesions in postauricular/mastoid region; 4. Previous facial nerve decompression surgery, or botulinum toxin injection in facial muscles within 3-6 months before enrollment; 5. Contraindications to magnetic stimulation (implanted electronic medical devices or metal implants near stimulation area); 6. Pregnancy or lactation; 7. Severe systemic diseases, or psychiatric/cognitive dysfunction that may affect treatment compliance or follow-up completion.

Design outcomes

Primary

MeasureTime frame
Responder rate of facial nerve function improvement;

Secondary

MeasureTime frame
Incidence of adverse events;Facial nerve conduction studies;Facial Disability Index;Functional near-infrared spectroscopy;Blink reflex;

Countries

China

Contacts

Public ContactSun Hui

Tongji Hospital of Tongji University

huisun@tongji.edu.cn+86 21 66111927

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Aug 10, 2026